Assess whether the carve-out is operable on day one (42e901)

SITUATION In a public acquirer facing HSR and sector regulators, QoE add-backs the seller marked 'normalized' is the evidence after add-backs that are just delayed opex. IP diligence counsel's financial counterpart has to pick Proceed or Reprice for this M&A Due Diligence Legal, IP, and Regulatory close using QoE add-backs the seller marked 'normalized'.

DECISION IP diligence counsel's financial counterpart in a public acquirer facing HSR and sector regulators must choose Proceed / Reprice / Walk / Hold using QoE add-backs the seller marked 'normalized' after add-backs that are just delayed opex.

HYPOTHESES TO TEST 1. The population in QoE add-backs the seller marked 'normalized' is the one add-backs that are just delayed opex named, so Proceed follows for this Legal, IP, and Regulatory file. 2. The population in QoE add-backs the seller marked 'normalized' is adjacent only to add-backs that are just delayed opex; Reprice is the honest M&A Due Diligence call. 3. A public acquirer facing HSR and sector regulators already contained add-backs that are just delayed opex before QoE add-backs the seller marked 'normalized' arrived; no new Legal, IP, and Regulatory path. 4. Provenance on QoE add-backs the seller marked 'normalized' after add-backs that are just delayed opex is broken; do not pick Proceed or Reprice yet.

ANALYSIS REQUIRED 1. Name the document IP diligence counsel's financial counterpart still needs before signing. 2. Test whether add-backs that are just delayed opex is a diligence gap, a price chip, or a walk-away. 3. Separate a one-off add-back from a recurring earnings issue in QoE add-backs the seller marked 'normalized'. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read QoE add-backs the seller marked 'normalized' against add-backs that are just delayed opex and write the one fact that would move the carve-out is operable for IP diligence counsel's financial counterpart.

RECOMMENDATION On this M&A Due Diligence / Legal, IP, and Regulatory decision, bind Proceed to QoE add-backs the seller marked 'normalized' after add-backs that are just delayed opex: if QoE add-backs the seller marked 'normalized' supports it, IP diligence counsel's financial counterpart executes Proceed in a public acquirer facing HSR and sector regulators and logs the owner. If QoE add-backs the seller marked 'normalized' instead fits Reprice, take that path. Where QoE add-backs the seller marked 'normalized' after add-backs that are just delayed opex is silent, IP diligence counsel's financial counterpart must do not proceed, reprice, or walk on a quality-of-earnings fact the packet does not carry.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on the carve-out is operable, then the evidence in QoE add-backs the seller marked 'normalized', then the action for IP diligence counsel's financial counterpart - Hypothesis scorecard against QoE add-backs the seller marked 'normalized': supported / rejected / untestable - Legal, IP, and Regulatory finding in QoE add-backs the seller marked 'normalized' that a second reviewer can re-perform - Missing page in QoE add-backs the seller marked 'normalized' after add-backs that are just delayed opex, if any